Pathogenesis of murine gammaherpesvirus-68 infection in interleukin-6- deficient mice

Virology

Volumn 249, Issue 2, 1998, Pages 359-366

  Sarawar, Sally R ^a,b   Brooks, James W ^a,c   Cardin, Rhonda D ^a   Mehrpooya, Mehdi ^a   Doherty, Peter C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b LIAI   (United States)

^c Transduction Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HERPES VIRUS; HOST RESISTANCE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RODENT DISEASE;

EID: 0032581939     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9309     Document Type: Article

References (26)

1. Allan W., Tabi Z., Cleary A., Doherty P. C. Cellular events in the lymph node and lung of mice with influenza: Consequences of depleting CD4+ T cells. J. Immunol. 144:1990;3980-3986.
2. Blaskovic D., Stancekova M., Svobodova J., Mistrikova J. Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol. 24:1980.
3. ++. J. Exp. Med. 184:1996;863-871.
4. Dalrymple S. A., Lucian L. A., Slattery R., McNeil T., Aud D. M., Fuchino S., Lee F., Murray R. Interleukin-6-deficient mice are highly susceptible toListeria monocytogenes. Infect. Immunol. 63:1995;2262-2268.
5. Efstathiou S., Ho Y. M., Hall S., Styles C. J., Scott S. D., Gompels U. A. Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus Saimiri. J. Gen. Virol. 71:1990;1365-1372.
6. Ehtisham S., Sunil Chandra N. P., Nash A. A. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67:1993;5247-5252.
7. Kanda T., McManus J. E., Nagai R., Imai S., Suzuki T., Yang D., McManus B. M., Kobayashi I. Modification of viral myocarditis in mice by interleukin-6. Circ. Res. 78:1996;848-856.
8. Keever Taylor C. A., Witt P. L., Truitt R. L., Ramanujam S., Borden E. C., Ritch P. S. Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: Evidence for monocyte activation. J. Immunother. Emphasis Tumor Immunol. 19:1996;231-243.
9. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 368:1994;339-342.
10. Lotz M., Jirik F., Kabouridis P., Tsoukas C., Hirano T., Kishimoto T., Carson D. A. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J. Exp. Med. 167:1988;1253-1258.
11. Malejczyk J., Malejczyk M., Urbanski A., Kock A., Jablonska S., Orth G., Luger T. A. Constitutive release of IL6 by human papillomavirus type 16 (HPV16)-harboring keratinocytes: A mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells. Cell Immunol. 136:1991;155-164.
12. McGhee J. R., Mestecky J., Elson C. O., Kiyono H. Regulation of IgA synthesis and immune response by T cells and interleukins. J. Clin. Immunol. 9:1989;175-199.
13. Miles S. A., Rezai A. R., Salazar Gonzalez J. F., Vander Meyden M., Stevens R. H., Logan D. M., Mitsuyasu R. T., Taga T., Hirano T., Kishimoto T., Martinez-Maza O. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. USA. 87:1990;4068-4072.
14. Nicholas J., Ruvolo V. R., Burns W. H., Sandford G., Wan X., Ciufo D., Hendrickson S. B., Guo H. G., Hayward G. S., Reitz M. S. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat. Med. 3:1997;287-292.
15. Rabinowich H., Sedlmayr P., Herberman R. B., Whiteside T. L. Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-alpha/beta secretion. J. Immunol. 150:1993;4844-4855.
16. Rogers L. A., Zlotnik A., Lee F., Shortman K. The maintenance of lytic specificity during the development of clones of cytotoxic T lymphocytes from single precursor cells. J. Immunol. Methods. 143:1991;241-250.
17. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., van Hinsbergh V., Sozzani S., Bussolino F., Poli V., Ciliberto G., Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6:1997;315-325.
18. Sarawar S. R., Cardin R. D., Brooks J. W., Mehrpooya M., Tripp R. A., Doherty P. C. Cytokine production in the immune response to murine gammaherpesvirus 68. J. Virol. 70:1996;3264-3268.
19. Sarawar S. R., Doherty P. C. Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J. Virol. 68:1994;3112-3119.
20. Sunil Chandra N. P., Arno J., Fazakerley J., Nash A. A. Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am. J. Pathol. 145:1994;818-826.
21. Sunil-Chandra N. P., Estathiou S., Arno J., Nash A. A. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J. Gen. Virol. 73:1992;2347-2356.
22. Tanner J., Tosato G. Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J. Clin. Invest. 88:1991;239-247.
23. Tosato G., Tanner J., Jones K. D., Revel M., Pike S. E. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J. Virol. 64:1990;3033-3041.
24. Usherwood E. J., Stewart J. P., Robertson K., Allen D. J., Nash A. A. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J. Gen. Virol. 77:1996;2819-2825.
25. Virgin H. W., Latreille P., Wamsley P., Hallsworth K., Weck K. E., Dal Canto A. J., Speck S. H. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:1997;5894-5904.
26. Weck K. E., Barkon M. L., Yoo L. I., Speck S. H., Virgin H. W. Mature B cells are required for acute splenic infection, but not for establishment of latency by murine gammaherpesvirus 68. J. Virol. 70:1996;6775-6780.